Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001144204-10-009096)

Filing Details

Accession Number:: 0001144204-10-009096
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-02-19 12:00:00
Reporting Period:: 2010-02-12

Filing Date:: 2010-02-19
Accepted Time:: 2010-02-19 17:14:05
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1137883	Brainstorm Cell Therapeutics Inc	BCLI	Biological Products, (No Disgnostic Substances) (2836)	912061050

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1318693	David Stolick	C/O Brainstorm Cell Therapeutics Inc. 110 East 59Th Street New York NY 10022	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2010-02-12	5,000	$0.36	395,000	No	4	S	Direct
Common Stock	Disposition	2010-02-16	3,000	$0.36	392,000	No	4	S	Direct
Common Stock	Disposition	2010-02-16	140,000	$0.36	252,000	No	4	S	Direct
Common Stock	Disposition	2010-02-17	2,000	$0.36	250,000	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Acquisiton	2010-02-12	400,000	$0.00	400,000	$0.15

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2015-02-13	No	4	M	Direct

Footnotes

The option is fully vested and exercisable